Xtx Topco LTD Rapt Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.72 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
13Shares Held
8.03MCall Options Held
0Put Options Held
0-
Medicxi Ventures Management (Jersey) LTD2.79MShares$80.6 Million10.91% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$70.4 Million0.0% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$46.1 Million52.54% of portfolio
-
Kpcb Xv Associates, LLC649KShares$18.7 Million43.54% of portfolio
-
Column Group LLC San Francisco, CA166KShares$4.79 Million5.41% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $856M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...